Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -848.74 M

Exact Sciences Corporation EBITDA is USD -848.74 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -11,504.73% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 7.44 M, a -102.56% change year over year.
  • Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -290.63 M, a -45.21% change year over year.
  • Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -530.48 M, a -31.04% change year over year.
  • Exact Sciences Corporation EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -769.21 M, a 326.41% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)